
Bavarian Nordic raises 2026 revenue and EBITDA margin forecasts after strong Travel Health sales.
Bavarian Nordic upgraded its full-year 2026 financial guidance due to stronger-than-expected sales in its Travel Health segment, particularly rabies vaccines in the U.S. Total revenue is now expected to reach approximately DKK 6,100 million, up from ...





